Cellulose, Microcrystalline — Drug Intelligence | 11 EU Trials

Filter these 11 trials by condition, phase, country and more.

Open in Search →

11 Registered trials

4 Recruiting

3 Completed trials

9 Sponsors

4 Countries

Phase III

Phase IV

Phase III: 5 Phase II: 1 Phase III/IV: 1 Phase IV: 3 Other: 1

Indications tested

H1N1 influenza 1

Sponsors using this IMP

Centre Hospitalier Universitaire Amiens Picardie 3 Amsterdam UMC Stichting 1 Centre Hospitalier Regional De Marseille 1 Centre Hospitalier Universitaire De Nantes 1 Dr. Douglas D. Fraser 1 Fundacio Institut D'Investigacio Biomedica De Bellvitge IDIBELL 1 Fundacion De La Comunitat Valenciana Para La Gestion Del Instituto De Investigacion Sanitaria Y Biomedica De Alicante 1 Radboud universitair medisch centrum Stichting 1 Universitair Medisch Centrum Utrecht 1

All trials

11 total

Long Covid (LC)-REVITALIZE - A Long Covid Repurposed Drug Study Not authorised

2025-522611-42-00 Phase III 1 country Dr. Douglas D. Fraser
Prolonged corticosteroid therapy in scheduled cardiac surgery in intermediate/high-risk patients: a prospective multicenter randomized contr… Pending

2024-517699-39-00 Phase III 1 country Centre Hospitalier Universitaire Amiens Picardie
Role of Vitamin C at 6 Months on Incidence of Complex Regional Pain Syndrome Type I in Upper Limb Surgery (CRPS-VITC) Pending

2024-518310-28-00 Phase III 1 country Centre Hospitalier Universitaire Amiens Picardie
Study evaluating the efficacy and safety of daridorexant in patients with major depressive disorder and insomnia. Pending

2025-524794-16-00 Phase IV 1 country Fundacio Institut D'Investigacio Biomedica De Bellvitge IDIBELL
Impact of prescribing nonsteroidal anti-inflammatory drugs in pleurodesis surgery after pneumothorax: a prospective randomized controlled do… Recruiting

2024-511226-32-00 Phase IV 1 country Centre Hospitalier Universitaire Amiens Picardie
Randomised, double-blind, multicentre, phase III clinical trial to evaluate the efficacy and safety of dexamethasone compared to placebo in … Recruiting

2024-513209-30-00 Phase III 1 country Fundacion De La Comunitat Valenciana Para La Gestion Del Instituto De Investigac…
RILUSCI Recruiting

2024-514882-20-00 1 country Centre Hospitalier Regional De Marseille
Contribution of an antiviral drug (Valaciclovir) in the treatment of generalized periodontitis (stage III or IV and grade A, B or C) Recruiting

2022-501957-35-00 Phase III 1 country Centre Hospitalier Universitaire De Nice
Dasatinib and quercetin, a combination of senolytics to treat fibrotic non-alcoholic fatty liver disease; The TRUTH study Ended

2024-517593-21-00 Phase II 1 country Amsterdam UMC Stichting
Understanding the Neurobiology of Pharmacologically-induced Acute Stress on Ethical Decisions Ended

2023-508731-31-01 Phase IV 1 country Universitair Medisch Centrum Utrecht
EDIT-CMD Ended

2024-512030-15-00 Phase III/IV 1 country Stichting Radboud universitair medisch centrum

Showing 1–11 of 11 trials

← All drugs A–Z